---
title: "Polaryx Therapeutics, Inc. (PLYX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/PLYX.US.md"
symbol: "PLYX.US"
name: "Polaryx Therapeutics, Inc."
industry: "制藥"
---

# Polaryx Therapeutics, Inc. (PLYX.US)

| Item | Detail |
|------|--------|
| Industry | 制藥 |
| Location | 美股市場 |
| Website | [olaryx.com](https://olaryx.com) |

## Company Profile

Polaryx Therapeutics, Inc.是一家臨床階段的生物技術公司，開發用于溶酶體儲存疾病的小分子和基因治療藥物。其產品管線包括 PLX-100，一種臨床前階段的口服組合療法；PLX-200，一種用于治療溶酶體儲存疾病的重新開發的口服小分子；PLX-300，一種臨床前階段的口服組合療法；以及 PLX-400，一種臨床前階段的新型基因治療候選藥物。該公司成立于 2014 年，總部位于新澤西州帕拉默斯

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -13.89 | 196/256 | - | - | - |
| PB | 21.52 | 183/256 | 196.04 | 52.96 | 26.08 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/PLYX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/PLYX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/PLYX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.